Cerebral atherosclerosis occurs spontaneously in homozygous WHHL rabbits

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 57-66

  Ito, Takashi ^a   Shiomi, Masashi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal models; Cerebral atherosclerosis; Choroid plexus; Homozygous WHHL rabbit; Xanthomatosis

Indexed keywords

CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

AGE; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LESION; ARTICLE; BRAIN ARTERY; BRAIN ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DISEASE ASSOCIATION; HISTOLOGY; HOMOZYGOSITY; HYPERTENSION; LIPID STORAGE; MACROPHAGE; NONHUMAN; PIA MATER; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL; XANTHOMA;

AGING; ANIMAL HUSBANDRY; ANIMALS; AORTA, THORACIC; ARTERIES; BLOOD PRESSURE; BRAIN DISEASES; CEREBRAL ARTERIES; CORONARY VESSELS; FEMALE; HOMOZYGOTE; HYPERLIPIDEMIAS; INTRACRANIAL ARTERIOSCLEROSIS; LIPIDS; MALE; PIA MATER; RABBITS; RECEPTORS, LDL; SEVERITY OF ILLNESS INDEX; XANTHOMATOSIS;

EID: 0035014538     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00622-5     Document Type: Article

References (36)

1. Murray C.J.L., Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 349:1997;1269-1276.
2. Kannel W.B. Role of blood pressure in cardiovascular morbidity and mortality. Prog. Cardiovasc. Dis. 17:1974;5-24.
3. Baker A.B., Resch J.A., Loewenson R.B. Hypertension and cerebral atherosclerosis. Circulation. 39:1969;701-710.
4. Sadoshima S., Kurozumi T., Tanaka K., et al. Cerebral and aortic atherosclerosis in Hisayama, Japan. Atherosclerosis. 36:1980;117-126.
5. Yamori Y., Horie R., Sato M., Fukase M. Hypertension as an important factor for cerebrovascular atherogenesis in rats. Stroke. 7:1976;120-125.
6. Imai H., Thomas W.A. Cerebral atherosclerosis in swine: role of necrosis in progression of diet-induced lesions from proliferative to atheromatous stage. Exp. Mol. Pathol. 8:1968;330-357.
7. Suzuki M. Experimental cerebral atherosclerosis in the dog, I. A morphologic study. Am. J. Pathol. 67:1972;387-402.
8. Prusty S., Kemper T., Moss M.B., Hollander W. Occurrence of stroke in a nonhuman primate model of cerebrovascular disease. Stroke. 19:1988;84-90.
9. Hosomi H., Katsuda S., Watanabe Y. Effect of atherosclerosis on the responsiveness of the rapidly acting arterial pressure control system in WHHL rabbits. Cardiovasc. Res. 20:1986;195-200.
10. Watanabe Y., Ito T., Shiomi M. The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits, an animal model for familial hypercholesterolemia. Atherosclerosis. 56:1985;71-79.
11. Shiomi M., Ito T., Shiraishi M., Watanabe Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis. 96:1992;43-52.
12. Buja L.M., Kita T., Goldstein J.L., Watanabe Y., Brown M.S. Cellular pathology of progressive atherosclerosis in the WHHL rabbit, an animal model of familial hypercholesterolemia. Arteriosclerosis. 3:1983;87-101.
13. Atkinson J.B., Swift L.L., Virmani R. Animal model of human disease, Watanabe heritable hyperlipidemic rabbits, familial hypercholesterolemia. Am. J. Pathol. 140:1992;749-753.
14. Watanabe Y. Studies on characteristics of spontaneously hyperlipidemic rabbits and development of the strains with such property. Bull. Azabu. Vet. Coll. 2:1977;99-124. in Japanese.
15. Iwabuchi S. A histological study on atherosclerosis of WHHL rabbit, with reference to carotid arteries and intracranial arteries. J. Jpn. Coll. Angiol. 28:1988;487-497. in Japanese.
16. Weber G, Bianciardi G, Centi L, Resi L, Salvi M, Tanganelli P. Delayed cerebral atherosclerosis involvement in WHHL rabbits. Crepaldi G, Gotto A.M, Manzato E, Baggio G, (editors). Atherosclerosis VIII. Amsterdam: Excerpta Medica, 1989: 125-128.
17. Kong J., Asada M., Tamaki N., et al. The effects of hypertension on experimental cerebral atherosclerosis. Cerebrovasc. Dis. 6:(Suppl. 2):1996;87.
18. Watanabe Y., Ito T., Shiomi M., et al. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim. Biophys. Acta. 960:1988;294-302.
19. Shiomi M., Ito T., Tsukada T., Yata T., Ueda M. Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ, an immunohistochemical study. Arterioscler. Thromb. 14:1994;931-937.
20. Tsukada T., Tippens D., Gordon D., Ross R., Gown A.M. HHF35, a muscle-actin-specific monoclonal antibody, I: immunocytochemical and biomedical characterization. Am. J. Pathol. 126:1987;51-69.
21. Tsukada T., Rosenfeld M.E., Ross R., Gown A.M. Immunocytochemical analysis of cellular components in atherosclerotic lesions: use of monoclonal antibodies with Watanabe and fat-fed rabbit. Arteriosclerosis. 6:1986;601-613.
22. Watanabe Y., Ito T., Shiomi M., et al. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim. Biophys. Acta. 960:1988;294-302.
23. Shiomi M., Ito T., Tsukada T., Tsujita Y., Horikoshi H. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits. Atherosclerosis. 142:1999;345-353.
24. Fisher C.M. Clinical picture of cerebral atherosclerosis. Minn. Med. 38:1955;839-851.
25. Resch J.A., Baker A.B. Etiologic mechanism in cerebral atherosclerosis. Arch. Neurol. 10:1964;617-628.
26. Resch J.A., Loewenson R.B., Baker A.B. Physical factors in the pathogenesis of cerebral atherosclerosis. Stroke. 1:1971;77-85.
27. Postiglione A., Nappi A., Brunetti A., et al. Relative protection from cerebral atherosclerosis of young patients with homozygous familial hypercholesterolemia. Atherosclerosis. 90:1991;23-30.
28. Watanabe T., Hirata M., Yoshikawa Y., Nagafuchi Y., Toyoshima H., Watanabe T. Role of macrophages in atherosclerosis, sequential observations of cholesterol-induced rabbit aortic lesions by the immunoperoxidase technique using monoclonal antibody. Lab. Invest. 53:1985;80-90.
29. Rosenfeld M.E., Tsukada T., Gown A.M., Ross R. Fatty streak initiation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 7:1987;9-23.
30. Kurozumi T. Electron microscopic study on permeability of the aorta and basilar artery of the rabbit-with special reference to the changes of permeability by hypercholesteremia. Exp. Mol. Pathol. 23:1975;1-11.
31. Chobanian A.V., Lichtenstein A.H., Nilakhe V., Haudenschild C.C., Drago R., Nickerson C. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension. 14:1989;203-209.
32. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-RABBIT), incidence and development of atherosclerosis and xanthoma. Atherosclerosis. 36:1980;261-268.
33. Tell G.S., Crouse J.R., Furberg C.D. Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A review. Stroke. 19:1988;423-430.
34. Grunnet M. Changes in cerebral arteries with aging. Arch. Pathol. 88:1969;314-318.
35. Shuangshoti S., Netsky M.G. Xanthogranuloma (xanthoma) of choroid plexus, the origin of foamy (xanthoma) cells. Am. J. Pathol. 48:1966;503-533.
36. Muenchau A., Laas R. Xanthogranuloma and xanthoma of the choroid plexus: evidence for different etiology and pathogenesis. Clin. Neuropathol. 16:1997;72-76.